Guided Therapeutics (GTHP) Asset Utilization Ratio (2012 - 2026)

Guided Therapeutics has disclosed Asset Utilization Ratio across 15 years of filings, most recently posting 0.46 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 275.3% year-over-year to 0.46; the TTM figure through Jun 2026 stood at 0.46 (up 275.3% YoY), while the FY2025 annual figure was 0.57, up 12256.19% from the prior year.
• Asset Utilization Ratio came in at 0.46 for Q2 2026 at Guided Therapeutics, down from 0.52 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.69 in Q4 2025 to a low of 0.0 in Q1 2025.
• Average Asset Utilization Ratio over 5 years is 0.13, with a median of 0.04 recorded in 2022.
• Year-over-year, Asset Utilization Ratio plunged 98.36% in 2025 and surged 61328.11% in 2026.
• Over 5 years, Asset Utilization Ratio stood at 0.0 in 2022, then surged by 1438.52% to 0.06 in 2023, then tumbled by 90.36% to 0.01 in 2024, then jumped by 12825.2% to 0.69 in 2025, then tumbled by 32.57% to 0.46 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.46 in Q2 2026, 0.52 in Q1 2026, and 0.69 in Q4 2025.